Boothbay Fund Management
$5.3B 13F equity value
2,416 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Boothbay Fund Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 465,787 | $87M | 1.6% |
| ABVX | ABIVAX SA | 563,367 | $75M | 1.4% |
| CLM | CORNERSTONE STRATEGIC INVEST | 6,736,737 | $51M | 1.0% |
| LQDA | LIQUIDIA CORPORATION | 622,716 | $50M | 0.9% |
| AMT | AMERICAN TOWER CORP | 285,457 | $47M | 0.9% |
| EQIX | EQUINIX INC | 43,907 | $46M | 0.9% |
| EXEL | EXELIXIS INC | 804,095 | $44M | 0.8% |
| STX | SEAGATE TECHNOLOGY HLDNGS PL | 42,220 | $41M | 0.8% |
| AMZN | AMAZON COM INC | 169,527 | $40M | 0.8% |
| BP | BP PLC | 986,363 | $36M | 0.7% |
Track Boothbay Fund Management's 13F portfolio: $5.3B in reported holdings, 2,416 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}